1. A pharmaceutical composition for oral administration containing as active agent at least one compound selected from the group consisting of: compound of formula (I) and compound of formula (II) wherein said active agent is in the form of active particles having a particle size smaller than 200 μm and a mean particle size of greater than 5 μm. 2. The composition of Claim 1 wherein the mean particle size of said active particles is between 10 and 100 μm. 3. The composition of Claim...

La presente invencion provee un metodo para tratar los sintomas de fotofobia y fonofobia de ataques de migrana con una cantidad efectiva de ibuprofeno una sal farmaceuticamente aceptable del mismo un isomero del mismo o una mezcla de los mismos..

The present invention relates to a cosmetic composition comprising (i) a compound selected from the group consisting of creatine carnitine and pyruvic acid and a cosmetically acceptable salt or ester thereof (ii) a nutrient and (iii) a skin-conditioning agent selected from the group consisting of an emollient and a humectant.

1. A method of inhibiting rejection of a tissue graft by a primate graft recipient comprising the step of administering an effective amount of a CD40:CD154 binding interruptor to the graft recipient wherein said CD40:CD154 binding interruptor is a blocking agent specifically bound with CD154 its antigen-binding fragment or a derivative thereof. 2. A method according to claim 1 wherein the anti-CD40L compound is a monoclonal antibody. 3. A method according to claim 2 wherein the monoclonal antibo...

1. A composition of matter comprising sertraline or a pharmaceutically acceptable salt thereof and an amount of a solubilizing agent sufficient to produce a concentration of dissolved sertraline in a use environment containing chloride ions which is 1.5 times higher than the concentration effected by a comparative composition of matter identical thereto but for the inclusion of said solubilizing agent provided said solubilizing agent is not alginic acid sodium citrate calcium carbonate a polyeth...

1. A pharmaceutical formulation comprising amoxycillin and clavulanate in a ratio of n: 1 where n is a number from 1 to 16 which comprises: a first set of granulates comprising amoxycillin and clavulanate in a ratio from 1:1 or 2:1; and a second set of granulates comprising amoxycillin and no clavulanate; providing to give an overall ratio between amoxycillin and clavulanate of n: 1 wherein the formulation when in the form of a tablet comprises the first and the second sets of granulates in a mi...

A bioadhesive wound-healing composition includes pullulan pyruvate an antioxidant and a mixture of saturated and unsaturated fatty acids. The composition can be provided in the form of a film that does not self-adhere. The composition can include additional medicinal agents such as polymyxin B sulfate bacitracin zinc and neomycin sulfate. Methods for producing the composition and methods for treating wounds with the composition are also disclosed.

Patente de Invenção: "COMPOSIçãO COMPREENDENDO UM MATERIAL DE TRAMADOL E UMA DROGA ANTICONVULSIVA". A presente invenção refere-se a uma composição farmacêutica compreendendo uma combinação de um material de tramadol e uma droga anticonvulsiva e ao uso farmacológico da composição no tratamento de dor e distúrbios neurológicos ou psiquiátricos. A composição produz um produto combinado tendo propriedades aperfeiçoadas requerendo menos de cada ingrediente e produzindo um efeito sinergístico.